[Effect of ligustrazine on nNOS expression and neuranagenesis in adult rats after cerebral ischemia-reperfusion injury]. 2007

Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
Research Center for Neuroscience, Department of Anatomy and Histology and Embryology, Medical School of Xi'an Jiaotong University, Xi'an 710061, China. qicunfang5008@sina.com

OBJECTIVE To observe the effect of ligustrazine on cell proliferation in the subventricular zone (SVZ) and dentate gyrus (DG) and nNOS expression in rat brain after cerebral ischemia-reperfusion injury. METHODS Male SD rats were randomly divided into normal control group, sham operation group, model group and ligustrazine treatment group. The latter two groups were further divided into 5 subgroups for observation at 1, 3, 7, 14 and 21 days after reperfusion following a 2-hour middle cerebral artery occlusion (MCAO). The cells in S phase were labeled with BrdU, and immunohistochemistry was employed to detect BrdU- and nNOS-positive cells. The numbers of BrdU-positive cells in the SVZ and DG were measured. The expression of nNOS was detected by Western blotting. RESULTS nNOS expression increased significantly in the model group as compared to the sham operation group (P<0.05), and ligustrazine treatment significantly lowered the expression level in comparison with the model group (P<0.05). Compared with the model group, a significant increase in BrdU-positive cells occurred in the SVZ of rats 1 and 3 days after igustrazine treatment (P<0.05), along with an increase of DG BrdU-positive cells. CONCLUSIONS Ligustrazine significantly restrains ischemia-reperfusion injury-induced nNOS activity enhancement and promotes cell proliferation in the SVZ and DG of adult rats after ischemia-reperfusion injury.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D009416 Nerve Regeneration Renewal or physiological repair of damaged nerve tissue. Nerve Tissue Regeneration,Nervous Tissue Regeneration,Neural Tissue Regeneration,Nerve Tissue Regenerations,Nervous Tissue Regenerations,Neural Tissue Regenerations,Regeneration, Nerve,Regeneration, Nerve Tissue,Regeneration, Nervous Tissue,Regeneration, Neural Tissue,Tissue Regeneration, Nerve,Tissue Regeneration, Nervous,Tissue Regeneration, Neural
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents

Related Publications

Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
May 2015, Neural regeneration research,
Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
November 2022, ACS biomaterials science & engineering,
Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
May 2007, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine,
Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
January 2014, Journal of Asian natural products research,
Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
October 2019, Human & experimental toxicology,
Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
September 2004, Transplantation proceedings,
Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
May 2007, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
August 2021, Life sciences,
Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
February 2015, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials,
Cun-fang Qi, and Yong Liu, and Jian-shui Zhang, and Yu-mei Tian, and Xin-lin Chen, and Peng-bo Zhang, and Xin-li Xiao, and Jun-feng Zhang
April 2012, Neural regeneration research,
Copied contents to your clipboard!